Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
topic_facet:"Recruitment Status: Complete: follow-up continuing"
topic_facet:"Medical Condition: (1) Therapeutic vaccine: Any hematological malignancies recurred after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML, ALL, CML, Multiple Myeloma, NHL).(2) Prophylactic vaccine: Hematological malignancies with high risk of relapse after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML in >=3CR/non-CR or any AML with M0/M6/M7 FAB type, ALL in >=2CR/non-CR, CML in >=2CP or >=AP, Multiple Myeloma in PD, NHL in non-CR)."
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Complete%3A+follow-up+continuing%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+%281%29+Therapeutic+vaccine%3A+Any+hematological+malignancies+recurred+after+allogineic+hematopoietic+transplanation+as+follows+%28RAEB%2C+CMML%2C+AML%2C+ALL%2C+CML%2C+Multiple+Myeloma%2C+NHL%29.%282%29+Prophylactic+vaccine%3A+Hematological+malignancies+with+high+risk+of+relapse+after+allogineic+hematopoietic+transplanation+as+follows+%28RAEB%2C+CMML%2C+AML+in+%26gt%3B%3D3CR%2Fnon-CR+or+any+AML+with+M0%2FM6%2FM7+FAB+type%2C+ALL+in+%26gt%3B%3D2CR%2Fnon-CR%2C+CML+in+%26gt%3B%3D2CP+or+%26gt%3B%3DAP%2C+Multiple+Myeloma+in+PD%2C+NHL+in+non-CR%29.%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Complete%3A+follow-up+continuing%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+%281%29+Therapeutic+vaccine%3A+Any+hematological+malignancies+recurred+after+allogineic+hematopoietic+transplanation+as+follows+%28RAEB%2C+CMML%2C+AML%2C+ALL%2C+CML%2C+Multiple+Myeloma%2C+NHL%29.%282%29+Prophylactic+vaccine%3A+Hematological+malignancies+with+high+risk+of+relapse+after+allogineic+hematopoietic+transplanation+as+follows+%28RAEB%2C+CMML%2C+AML+in+%26gt%3B%3D3CR%2Fnon-CR+or+any+AML+with+M0%2FM6%2FM7+FAB+type%2C+ALL+in+%26gt%3B%3D2CR%2Fnon-CR%2C+CML+in+%26gt%3B%3D2CP+or+%26gt%3B%3DAP%2C+Multiple+Myeloma+in+PD%2C+NHL+in+non-CR%29.%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Complete%3A+follow-up+continuing%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+%281%29+Therapeutic+vaccine%3A+Any+hematological+malignancies+recurred+after+allogineic+hematopoietic+transplanation+as+follows+%28RAEB%2C+CMML%2C+AML%2C+ALL%2C+CML%2C+Multiple+Myeloma%2C+NHL%29.%282%29+Prophylactic+vaccine%3A+Hematological+malignancies+with+high+risk+of+relapse+after+allogineic+hematopoietic+transplanation+as+follows+%28RAEB%2C+CMML%2C+AML+in+%26gt%3B%3D3CR%2Fnon-CR+or+any+AML+with+M0%2FM6%2FM7+FAB+type%2C+ALL+in+%26gt%3B%3D2CR%2Fnon-CR%2C+CML+in+%26gt%3B%3D2CP+or+%26gt%3B%3DAP%2C+Multiple+Myeloma+in+PD%2C+NHL+in+non-CR%29.%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
PubPharm (2)
1
Predetermined Minor Histocompatibility Antigen-based Therapeutic or Prophylactic Peptide Vaccinations for Patients with Recurred Malignancies or Patients with High-Risk Malignancies Follwoing Allogeneic Hematopoietic Cell Transplantation. : Predetermined Minor Histocompatibility Antigen-based Therapeutic or Prophylactic Peptide Vaccinations for Patients with Recurred Malignancies or Patients with High-Risk Malignancies Follwoing Allogeneic Hematopoietic Cell Transplantation. - Prevention or Treatment of Recurring Malignancies after Allongeneic Transplantation with Minor Antigen Peptides
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Predetermined Minor Histocompatibility Antigen-based Therapeutic or Prophylactic Peptide Vaccinations for Patients with Recurred Malignancies or Patients with High-Risk Malignancies Follwoing Allogeneic Hematopoietic Cell Transplantation. : Predetermined Minor Histocompatibility Antigen-based Therapeutic or Prophylactic Peptide Vaccinations for Patients with Recurred Malignancies or Patients with High-Risk Malignancies Follwoing Allogeneic Hematopoietic Cell Transplantation. - Prevention or Treatment of Recurring Malignancies after Allongeneic Transplantation with Minor Antigen Peptides
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Thema: Recruitment Status: Complete: follow-up continuing
Filter aufheben
Thema: Medical Condition: (1) Therapeutic vaccine: Any hematological malignancies recurred after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML, ALL, CML, Multiple Myeloma, NHL).(2) Prophylactic vaccine: Hematological malignancies with high risk of relapse after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML in >=3CR/non-CR or any AML with M0/M6/M7 FAB type, ALL in >=2CR/non-CR, CML in >=2CP or >=AP, Multiple Myeloma in PD, NHL in non-CR).
Medienart
2
Aufsätze
2
E-Artikel
2
E-Ressourcen
Zeitschriftentitel
2
WHO International Clinical Trials Registry Plat...
Thema
2
610
Medical Condition: (1) Therapeutic vaccine: Any...
Phase: Phase 1
Recruitment Status: Complete: follow-up continuing
2
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2
Englisch
Haven't found what you're looking for?
Wird geladen...